You just read:

Cempra Pharmaceuticals Presents New Data on Its Multi-Drug Resistant Anti-Infective Portfolio, Solithromycin (CEM-101) and TAKSTA™ (CEM-102), at The 48th Annual Meeting of The Infectious Diseases Society Of America

News provided by

Cempra Pharmaceuticals

Oct 15, 2010, 08:00 ET